Health care stocks were flat to lower premarket Thursday with the iShares Biotechnology ETF (IBB) recently inactive and the Health Care Select Sector SPDR Fund (XLV) down 0.5% recently.
UnitedHealth Group (UNH) shares were down nearly 4% after the company reported a lower-than-expected Q4 revenue.
Incyte (INCY) and Syndax Pharmaceuticals (SNDX) said the US Food and Drug Administration has approved Niktimvo as a treatment for certain patients with chronic graft-versus-host disease who weigh at least 40 kg. Syndax Pharmaceuticals shares were 2% higher premarket.
Seres Therapeutics (MCRB) said it received a $50 million installment related to the sale of its VOWST business to Societe des Produits Nestle. Seres Therapeutics shares were down nearly 4% pre-bell.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.